Dwivedi; Anil Kumar

Patent Applications and Registrations

Patent applications and USPTO patent grants for Dwivedi; Anil Kumar.The latest application filed is for "chiral 1-(4-methylphenylmethyl)-5-oxo--pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion".

Company Profile

0.10.9

Dwivedi; Anil Kumar - Lucknow IN
Dwivedi; Anil Kumar - Uttar Pradesh IN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chiral 1-(4-methylphenylmethyl)-5-oxo-{N-[(3-t-butoxycarbonyl-aminomethyl)- ]-piperidin-1-yl)-pyrrolidine as inhibitors of collagen induced platelet activation and adhesion Grant 9,687,480 - Dikshit , et al. June 27, 2	2017-06-27
Chiral 1-(4-methylphenylmethyl)-5-oxo--pyrrolidine-2-carboxamides As Inhibitors Of Collagen Induced Platelet Activation And Adhesion App 20160143896 - DIKSHIT; Dinesh Kumar ; et al.	2016-05-26
Pregnane-oximino-aminoalkylethers And Process For Preparation Thereof, Useful As Antidiabetic And Antidyslipidemic Agents App 20160009752 - VERMA; Prem Chandra ; et al.	2016-01-14
Chiral 1-(4-methylphenylmethyl)-5-OXO-{N-[3-T-butoxycarbonyl-aminomethyl)]- -piperidin-1-yl-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion Grant 9,206,155 - Dikshit , et al. December 8, 2	2015-12-08
Substituted benzfurochromenes and related compounds for the prevention and treatment of bone related disorders Grant 8,686,028 - Goel , et al. April 1, 2	2014-04-01
Chiral 1-(4-methylphenylmethyl)-5-oxo--pyrrolidine-2-carboxamides As Inhibitors Of Collagen Induced Platelet Activation And Adhesion App 20130338193 - Dikshit; Dinesh Kumar ; et al.	2013-12-19
Controlled release micro-capsule for osteogenic action Grant 8,496,964 - Mishra , et al. July 30, 2	2013-07-30
Substituted Benzfurochromenes And Related Compounds For The Prevention And Treatment Of Bone Related Disorders App 20120003273 - Goel; Atul ; et al.	2012-01-05
Controlled Release Micro-capsule For Osteogenic Action App 20110305754 - Mishra; Prabhat Ranjan ; et al.	2011-12-15
R-(-) / S-(+)-7-[3-n Substituted Amino-2 Hydroxypropoxy] Flavones App 20110077294 - Pratap; Ram ; et al.	2011-03-31
Combination kit used in the treatment of malaria Grant 7,404,962 - Pinto , et al. July 29, 2	2008-07-29
Method for the treatment of malaria by the use of primaquine derivative N.sup.1-(3-ethylidinotetrahydrofuran-2-one)-N.sup.4- (6-methoxy-8-quinolinyl)-1,4-pentanediamine as gametocytocidal agent Grant 7,183,291 - Pratap , et al. February 27, 2	2007-02-27
Polypeptide useful as antiallergic/antiasthmatic activity, methods for the preparation thereof, pharmaceutical compositions containing such polypeptide and use thereof App 20060160989 - Kundu; Bijoy ; et al.	2006-07-20
Inclusion complees of a high potent opioid peptide, pharmaceutical compositions and method of treatment Grant 6,740,639 - Dwivedi , et al. May 25, 2	2004-05-25
Method For The Treatment Of Malaria By The Use Of Primaquine Derivative N1-(3-ethylidinotetrahydrofuran-2-one) -n 4-(6-methoxy-8-quinolinyl)-1,4-- Pentanediamine As Gametocytocidal Agent App 20030199697 - PRATAP, RAM ; et al.	2003-10-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.